ALPACA (J3L-MC-EZEB)
LY3473329 Lp(a) siRNA (subcutane) for secondary MACE prevention in patients with elevated Lp(a)
- Stadium
- klaar
- Middel
- LY3819469 Lp(a) siRNA (subcutaan)
- Populatie
- ASCVD
- Fase
- II
- First Patient In
- 9 februari 2023
- Last Patient In
- 17 april 2023
- Last Patient Last Visit
- 7 oktober 2024
Studiedirecteur
dr. M.F.L. Meijs
Cardioloog
Contact Kantoor
